Social Optimization Study

Conditions

• Lung Cancer

Eligibility Criteria

Sex

ALL

Age

18 Years - 99 Years

Healthy Volunteers

Not accepted

Interventions

• Social support receptivity training — BEHAVIORAL
  A 3-week, 6-session CBT intervention that targets cognitive awareness of prosocial cues and leverages behavioral activation and social skills training
• Social awareness training — BEHAVIORAL
  A 3-week, 6 session program designed to increase awareness of available social support.

Study Details

This study tests whether clinical interventions to optimize support receptivity lead to improvements in social integration and quality of life (QOL) amongst long-term lung cancer survivors. The feasibility and acceptability of the intervention and assessment procedures will be examined. Thirty long-term lung cancer survivors will be randomized to a support receptivity intervention or an attention-control condition. Our intervention draws on cognitive behavioral therapy (CBT) strategies to reduce social anxiety, improve social awareness, and promote social integration. We will use two novel in vivo sampling methods using a mobile phone platform to assess social engagement and QOL improvements: 1) recording via the Electronically Activated Recorder to capture daily social interactions, and 2) repeated self-report sampling where participants answer questions about their social engagement experiences via their personal cell phone.

Key Dates

Start date

Apr 27, 2026

Status verified

Jun 2026

Primary completion

Jul 31, 2026

Completion

Jul 31, 2026

Study Design

Enrollment

30 participants (estimated)

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Arms

• Experimental: Social support receptivity training
  Participants will receive a 3-week, 6 session CBT intervention targeting cognitive awareness of prosocial cues coupled with behavioral activation and social skills training to improve target person social engagement.
• Active Comparator: Social awareness training
  Participants receiving a 3-week, 6 session program designed to increase awareness of the social support already available to them.

Primary Outcome Measure

Feasibility assessed by recruitment and retention rates [ Time Frame: Throughout the recruitment period ]

Central Contacts

• Francis Morales-Lozada
  (520) 621-0563
  [email protected]

Locations (1)

Find similar trials in Tucson, AZ

Related Studies

• RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
  PHASE2 · Recruiting · Masonic Cancer Center, University of Minnesota · Phoenix, Arizona
• Adaptive Symptom Self-Management Immunotherapy Study
  Recruiting · University of Arizona · Phoenix, Arizona
• A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
  PHASE1/PHASE2 · Recruiting · A2 Biotherapeutics Inc. · Gilbert, Arizona
• A Registry for People With Lung Cancer
  Recruiting · Memorial Sloan Kettering Cancer Center · Tucson, Arizona